Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Korean Red Ginseng attenuates ethanol-induced steatosis and oxidative stress via AMPK/Sirt1 activation

  • Han, Jae Yun (College of Pharmacy, Chosun University) ;
  • Lee, Sangkyu (College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University) ;
  • Yang, Ji Hye (College of Pharmacy, Chosun University) ;
  • Kim, Sunju (College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University) ;
  • Sim, Juhee (College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University) ;
  • Kim, Mi Gwang (College of Pharmacy, Chosun University) ;
  • Jeong, Tae Cheon (College of Pharmacy, Yeungnam University) ;
  • Ku, Sae Kwang (MRC-GHF, College of Korean Medicine, Daegu Haany University) ;
  • Cho, Il Je (MRC-GHF, College of Korean Medicine, Daegu Haany University) ;
  • Ki, Sung Hwan (College of Pharmacy, Chosun University)
  • Received : 2014.07.08
  • Accepted : 2014.09.01
  • Published : 2015.04.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Alcoholic steatosis is the earliest and most common liver disease, and may precede the onset of more severe forms of liver injury. Methods: The effect of Korean Red Ginseng extract (RGE) was tested in two murine models of ethanol (EtOH)-feeding and EtOH-treated hepatocytes. Results: Blood biochemistry analysis demonstrated that RGE treatment improved liver function. Histopathology and measurement of hepatic triglyceride content verified the ability of RGE to inhibit fat accumulation. Consistent with this, RGE administration downregulated hepatic lipogenic gene induction and restored hepatic lipolytic gene repression by EtOH. The role of oxidative stress in the pathogenesis of alcoholic liver diseases is well established. Treatment with RGE attenuated EtOH-induced cytochrome P450 2E1, 4-hydroxynonenal, and nitrotyrosine levels. Alcohol consumption also decreased phosphorylation of adenosine monophosphate-activated protein kinase, which was restored by RGE. Moreover, RGE markedly inhibited fat accumulation in EtOH-treated hepatocytes, which correlated with a decrease in sterol regulatory element-binding protein-1 and a commensurate increase in sirtuin 1 and peroxisome proliferator-activated receptor-a expression. Interestingly, the ginsenosides Rb2 and Rd, but not Rb1, significantly inhibited fat accumulation in hepatocytes. Conclusion: These results demonstrate that RGE and its ginsenoside components inhibit alcoholic steatosis and liver injury by adenosine monophosphate-activated protein kinase/sirtuin 1 activation both in vivo and in vitro, suggesting that RGE may have a potential to treat alcoholic liver disease.

Keywords

References

  1. Frazier TH, Stocker AM, Kershner NA, Marsano LS, McClain CJ. Treatment of alcoholic liver disease. Therap Adv Gastroenterol 2011;4:63-81. https://doi.org/10.1177/1756283X10378925
  2. Gramenzi A, Caputo F, Biselli M, Kuria F, Loggi E, Andreone P, Bernardi M. Review article: alcoholic liver disease - pathophysiological aspects and risk factors. Aliment Pharmacol Ther 2006;24:1151-61. https://doi.org/10.1111/j.1365-2036.2006.03110.x
  3. Dey A, Cederbaum AI. Alcohol and oxidative liver injury. Hepatology 2006;43: S63-74. https://doi.org/10.1002/hep.20957
  4. Lu Y, Cederbaum AI. CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med 2008;44:723-38. https://doi.org/10.1016/j.freeradbiomed.2007.11.004
  5. Morgan K, French SW, Morgan TR. Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology 2002;36:122-34.
  6. Lu Y, Wu D, Wang X, Ward SC, Cederbaum AI. Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice. Free Radic Biol Med 2010;49:1406-16. https://doi.org/10.1016/j.freeradbiomed.2010.07.026
  7. Morimoto M, Hagbjork AL, Wan YJ, Fu PC, Clot P, Albano E, Ingelman- Sundberg M, French SW. Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors. Hepatology 1995;21:1610-7.
  8. Morimoto M, Reitz RC, Morin RJ, Nguyen K, Ingelman-Sundberg M, French SW. CYP-2E1 inhibitors partially ameliorate the changes in hepatic fatty acid composition induced in rats by chronic administration of ethanol and a high fat diet. J Nutr 1995;125:2953-64.
  9. Gouillon Z, Lucas D, Li J, Hagbjork AL, French BA, Fu P, Fang C, Ingelman- Sundberg M, Donohue Jr TM, French SW. Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole. Proc Soc Exp Biol Med 2000;224:302-8. https://doi.org/10.1046/j.1525-1373.2000.22435.x
  10. Purohit V, Gao B, Song BJ. Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 2009;33:191-205. https://doi.org/10.1111/j.1530-0277.2008.00827.x
  11. You M, Fischer M, Deeg MA, Crabb DW. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem 2002;277:29342-7. https://doi.org/10.1074/jbc.M202411200
  12. Mandard S, Muller M, Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci 2004;61:393-416. https://doi.org/10.1007/s00018-003-3216-3
  13. Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Park O, Luo Z, Lefai E, Shyy JY, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 2011;13:376-88. https://doi.org/10.1016/j.cmet.2011.03.009
  14. You M, Liang X, Ajmo JM, Ness GC. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. Am J Physiol Gastrointest Liver Physiol 2008;294:G892-8. https://doi.org/10.1152/ajpgi.00575.2007
  15. Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, Li X. Hepatocytespecific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab 2009;9:327-38. https://doi.org/10.1016/j.cmet.2009.02.006
  16. Choi KT. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol Sin 2008;29: 1109-18. https://doi.org/10.1111/j.1745-7254.2008.00869.x
  17. Lu JM, Yao Q, Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol 2009;7:293-302. https://doi.org/10.2174/157016109788340767
  18. Kim WY, Kim JM, Han SB, Lee SK, Kim ND, Park MK, Kim CK, Park JH. Steaming of ginseng at high temperature enhances biological activity. J Nat Prod 2000;63:1702-4. https://doi.org/10.1021/np990152b
  19. Kasai R, Besso H, Tanaka O, Saruwatari Y, Fuwa T. Saponins of red ginseng. Chem Pharmaceut Bull 1983;31:2120-5. https://doi.org/10.1248/cpb.31.2120
  20. Kim YS, Kim YH, Noh JR, Cho ES, Park JH, Son HY. Protective effect of Korean Red Ginseng against aflatoxin B1-induced hepatotoxicity in rat. J Ginseng Res 2011;35:243-9. https://doi.org/10.5142/jgr.2011.35.2.243
  21. Gum SI, Cho MK. Korean Red Ginseng extract prevents APAP-induced hepatotoxicity through metabolic enzyme regulation: the role of ginsenoside Rg3, a protopanaxadiol. Liver Int 2013;33:1071-84. https://doi.org/10.1111/liv.12046
  22. Kwon YS, Jang KH. The effect of Korean red ginseng on liver regeneration after 70% hepatectomy in rats. J Vet Med Sci 2004;66:193-5. https://doi.org/10.1292/jvms.66.193
  23. KiSH, Yang JH, KuSK,KimSC, KimYW, Cho IJ. Red ginseng extract protects against carbon tetrachloride-induced liver fibrosis. J Ginseng Res 2013;37:45-53. https://doi.org/10.5142/jgr.2013.37.45
  24. Ki SH, Choi JH, Kim CW, Kim SG. Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity. Chem Biol Interact 2007;169:80-90. https://doi.org/10.1016/j.cbi.2007.05.008
  25. Ki SH, Park O, Zheng M, Morales-Ibanez O, Kolls JK, Bataller R, Gao B. Interleukin- 22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 2010;52:1291-300. https://doi.org/10.1002/hep.23837
  26. Bertola A, Mathews S, Ki SH, Wang H, Gao B. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc 2013;8:627-37. https://doi.org/10.1038/nprot.2013.032
  27. Galligan JJ, Smathers RL, Fritz KS, Epperson LE, Hunter LE, Petersen DR. Protein carbonylation in a murine model for early alcoholic liver disease. Chem Res Toxicol 2012;25:1012-21. https://doi.org/10.1021/tx300002q
  28. Zhou Z, Wang L, Song Z, Saari JT, McClain CJ, Kang YJ. Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am J Pathol 2005;166:1681-90. https://doi.org/10.1016/S0002-9440(10)62478-9
  29. Ishak KG, Zimmerman HJ, Ray MB. Alcoholic liver disease: pathologic, pathogenetic and clinical aspects. Alcohol Clin Exp Res 1991;15:45-66. https://doi.org/10.1111/j.1530-0277.1991.tb00518.x
  30. Altamirano J, Bataller R. Alcoholic liver disease: pathogenesis and new targets for therapy. Nat Rev Gastroenterol Hepatol 2011;8:491-501. https://doi.org/10.1038/nrgastro.2011.134
  31. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011;141:1572-85. https://doi.org/10.1053/j.gastro.2011.09.002
  32. Yin H, Hu M, Liang X, Ajmo JM, Li X, Bataller R, Odena G, Stevens Jr SM, You M. Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver. Gastroenterology 2014;146:801-11. https://doi.org/10.1053/j.gastro.2013.11.008
  33. Aroor AR, Shukla SD. Binge ethanol intake in chronically exposed rat liver decreases LDL-receptor and increases angiotensinogen gene expression. World J Hepatol 2011;3:250-5. https://doi.org/10.4254/wjh.v3.i9.250
  34. You M, Matsumoto M, Pacold CM, Cho WK, Crabb DW. The role of AMPactivated protein kinase in the action of ethanol in the liver. Gastroenterology 2004;127:1798-808. https://doi.org/10.1053/j.gastro.2004.09.049
  35. Canto C, Auwerx J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol 2009;20:98-105. https://doi.org/10.1097/MOL.0b013e328328d0a4
  36. Shen Z, Liang X, Rogers CQ, Rideout D, You M. Involvement of adiponectin- SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 2010;298: G364-74. https://doi.org/10.1152/ajpgi.00456.2009

Cited by

  1. Heme oxygenase-1 alleviates alcoholic liver steatosis: histopathological study vol.29, pp.1, 2016, https://doi.org/10.1293/tox.2015-0035
  2. Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination? vol.22, pp.1, 2015, https://doi.org/10.3748/wjg.v22.i1.8
  3. Metabolism of 20(S)-Ginsenoside Rg2 by Rat Liver Microsomes: Bioactivation to SIRT1-Activating Metabolites vol.21, pp.6, 2015, https://doi.org/10.3390/molecules21060757
  4. 알코올로 유도된 간 손상 동물모델에서 굴 추출물의 간 보호 효과 vol.45, pp.6, 2016, https://doi.org/10.3746/jkfn.2016.45.6.805
  5. Ginseng for Liver Injury: Friend or Foe? vol.3, pp.4, 2016, https://doi.org/10.3390/medicines3040033
  6. Korean red ginseng extract enhances paclitaxel distribution to mammary tumors and its oral bioavailability by P-glycoprotein inhibition vol.47, pp.5, 2017, https://doi.org/10.1080/00498254.2016.1182233
  7. Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical Relevance vol.17, pp.3, 2015, https://doi.org/10.3727/105221617x695519
  8. Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK vol.18, pp.6, 2017, https://doi.org/10.3390/ijms18051063
  9. Synergetic Hepatoprotective Effects of Korean Red Ginseng and Pueraria Radix on the Liver Damaged-Induced by Carbon Tetrachloride (CCl4) in Mice vol.23, pp.2, 2017, https://doi.org/10.20307/nps.2017.23.2.132
  10. Protective effect of Korean Red Ginseng against FK506-induced damage in LLC-PK1 cells vol.41, pp.3, 2015, https://doi.org/10.1016/j.jgr.2016.05.002
  11. Protection Effect of Cyanidin 3-O-Glucoside Against Oxidative Stress-induced HepG2 Cell Death Through Activation of Akt and Extracellular Signal-regulated Kinase Pathways : Hepatoprotective Effect of vol.38, pp.11, 2017, https://doi.org/10.1002/bkcs.11290
  12. Towards natural mimetics of metformin and rapamycin vol.9, pp.11, 2015, https://doi.org/10.18632/aging.101319
  13. 20(S)-Ginsenoside Rg2 attenuates myocardial ischemia/reperfusion injury by reducing oxidative stress and inflammation: role of SIRT1 vol.8, pp.42, 2018, https://doi.org/10.1039/c8ra02316f
  14. Beneficial Effects of Korean Red Ginseng in the Progression of Non-Alcoholic Steatohepatitis via FABP4 Modulation vol.46, pp.7, 2015, https://doi.org/10.1142/s0192415x18500817
  15. Protective Effect of Isoliquiritigenin against Ethanol-Induced Hepatic Steatosis by Regulating the SIRT1-AMPK Pathway vol.34, pp.1, 2015, https://doi.org/10.5487/tr.2018.34.1.023
  16. Protective effect of Korean red ginseng on oxaliplatin-mediated splenomegaly in colon cancer vol.95, pp.3, 2018, https://doi.org/10.4174/astr.2018.95.3.161
  17. Ginseng ( Panax ginseng Meyer) Oligopeptides Protect Against Binge Drinking-Induced Liver Damage through Inhibiting Oxidative Stress and Inflammation in Rats vol.10, pp.11, 2015, https://doi.org/10.3390/nu10111665
  18. Astaxanthin alleviated ethanol-induced liver injury by inhibition of oxidative stress and inflammatory responses via blocking of STAT3 activity vol.8, pp.None, 2015, https://doi.org/10.1038/s41598-018-32497-w
  19. Orally administration of Neolentinus lepideus extracts attenuated ethanol induced accumulation of hepatic lipid in mice vol.28, pp.1, 2015, https://doi.org/10.1007/s10068-018-0451-9
  20. Ameliorative effect of black ginseng extract against oxidative stress-induced cellular damages in mouse hepatocytes vol.43, pp.2, 2015, https://doi.org/10.1016/j.jgr.2017.10.003
  21. Arginyl-fructosyl-glucose, a Major Maillard Reaction Product of Red Ginseng, Attenuates Cisplatin-Induced Acute Kidney Injury by Regulating Nuclear Factor κB and Phosphatidylinositol 3-Kinase/Pr vol.67, pp.20, 2015, https://doi.org/10.1021/acs.jafc.9b00540
  22. Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease vol.20, pp.11, 2015, https://doi.org/10.3390/ijms20112712
  23. Natural compounds in the chemoprevention of alcoholic liver disease vol.33, pp.9, 2015, https://doi.org/10.1002/ptr.6410
  24. Linking Dysregulated AMPK Signaling and ER Stress in Ethanol-Induced Liver Injury in Hepatic Alcohol Dehydrogenase Deficient Deer Mice vol.9, pp.10, 2015, https://doi.org/10.3390/biom9100560
  25. Extension of Drosophila lifespan by Korean red ginseng through a mechanism dependent on dSir2 and insulin/IGF-1 signaling vol.11, pp.21, 2015, https://doi.org/10.18632/aging.102387
  26. Antidiabetic Effects of Arginyl-Fructosyl-Glucose, a Nonsaponin Fraction from Ginseng Processing in Streptozotocin-Induced Type 2 Diabetic Mice through Regulating the PI3K/AKT/GSK-3 β and Bcl-2/ vol.2020, pp.None, 2015, https://doi.org/10.1155/2020/3707904
  27. Bifenthrin exerts proatherogenic effects via arterial accumulation of native and oxidized LDL in rats: the beneficial role of vitamin E and selenium vol.27, pp.6, 2015, https://doi.org/10.1007/s11356-018-3771-7
  28. Botanical Medicine and Phytochemicals in Healthy Aging and Longevity-Part 2 vol.26, pp.2, 2015, https://doi.org/10.1089/act.2020.29268.kha
  29. Ginsenoside Rg2 Ameliorates High-Fat Diet-Induced Metabolic Disease through SIRT1 vol.68, pp.14, 2015, https://doi.org/10.1021/acs.jafc.0c00833
  30. Lactobacillus fermentum KP-3-fermented ginseng ameliorates alcohol-induced liver disease in C57BL/6N mice through the AMPK and MAPK pathways vol.11, pp.11, 2015, https://doi.org/10.1039/d0fo02396e
  31. Oxidative Stress-A Key Player in the Course of Alcohol-Related Liver Disease vol.10, pp.14, 2021, https://doi.org/10.3390/jcm10143011